- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
2
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
Daiichi Sankyo Company
Market Cap: JP¥6.6t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568
JP¥3,520.00
7D
-1.9%
1Y
-41.5%
Chugai Pharmaceutical
Market Cap: JP¥10.7t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,486.00
7D
7.9%
1Y
-8.9%